IFNG and disease arising from reactivation of latent virus: A therapeutic vaccine has certain requirements: it must induce Th1-type cytokines such as IFN-γ and TNF, promote the activation of infected macrophages, and prevent reactivation of latent infection and transmission of pathogens to other people (107, 108).